Patent ID: 7199243

Claim:
A compound of Formula I or a pharmaceutically acceptable salt of said compound wherein F and G are each independently a) hydrogen, b) halo, c) (C 1 –C 4 )alkyl or d) (C 1 –C 4 )alkoxy; X is a)-Z or b) O—C(R 1 R 2 )-Z; Z is a) —C(O)OH, b) —C(O)O—(C 1 –C 4 )alkyl, c) —C(O)—NH 2 , or d) tetrazolyl; R 1 is a) H, or b) methyl; R 2 is a) H, b) methyl or c) —O—CH 2 -phenyl; W is a) a bond, b) oxy c) —N(H)—, d) —NH—(C 1 –C 4 )alkyl-, e) —(C 1 –C 4 f) —(C 1 –C 4 )alkyl-O; or g) CR 7 R 8 wherein R 7 and R 8 are linked together to form a three membered fully saturated carbocyclic ring; A is a) phenyl optionally independently substituted with one or two 1) —(C 1 –C 6 )alkyl, 2) —CF 3 , 3)—OCF 3 4) —(C 1 –C 6 )alkoxy, 5) (C 3 –C 6 )cycloalkyl, 6) halo or 7) hydroxy; or b) thiazolyl optionally independently substituted with 1) one or two methyl or 2) phenyl optionally independently substituted with one or two a) —(C 1 –C 6 )alkyl, b) —CF 3 , c) —OCF 3 , d) —(C 1 –C 6 )alkoxy, e) (C 3 –C 7 )cycloalkyl, f) halo, g) —(C 1 –C 4 )alkylthio or h) hydroxy; provided that: and when, W is a bond, X is O—C(R 1 R 2 )-Z, wherein R 1 and R 2 are each hydrogen, and Z is —C(O)OH or —C(O)O—(C 1 –C 4 )alkyl, then one of F or G must be a)—(C 1 –C 4 )alkyl, or b) (C 1 –C 4 )alkoxy.